Akèy › Leksemi mieloïd egi › Kalifòni › Mountain View
Etid klinik pou Leksemi mieloïd egi nan Mountain View, CA
19 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Mountain View (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Ap rekriteFaz 1
- Stanford Health Care, Stanford · 5 mi lwen
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi lwen
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Ap rekriteFaz 2
- Stanford Cancer Institute, Stanford · 5 mi lwen
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Ap rekriteFaz 1
- Lucile Packard Children's Hospital /ID# 276015, Palo Alto · 5 mi lwen
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi lwen
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Ap rekriteFaz 1
- Lucille Packard Children's Hospital of Stanford University, Palo Alto · 5 mi lwen
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Ap rekriteFaz 1
- Stanford University, Palo Alto · 5 mi lwen
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Ap rekriteFaz 1
- Stanford University, Palo Alto · 5 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Stanford University Medical Center, Stanford · 5 mi lwen
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Ap rekriteFaz 1
- Stanford University, Palo Alto · 5 mi lwen
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Ap rekriteFaz 1
- Stanford University, Stanford · 5 mi lwen
Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
Ap rekriteFaz 1/2
- Stanford University, Palo Alto · 5 mi lwen
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Ap rekriteFaz 1/2
- Stanford University, Palo Alto · 5 mi lwen
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- Stanford, Palo Alto · 5 mi lwen
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Ap rekriteFaz 1
- Stanford Medical Center, Palo Alto · 5 mi lwen
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Ap rekriteFaz 1
- Stanford University, Stanford · 5 mi lwen
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Ap rekriteFaz 1
- Stanford Cancer Center, Palo Alto · 5 mi lwen
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1/2
- Stanford Cancer Center, Palo Alto · 5 mi lwen
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Ap rekriteVolontè an sante akeyi
- Stanford University, Stanford · 5 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Baldwin Park, CA40 etid
- Seattle, WA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA30 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan Mountain View
- Kansè (tout kalite)40 etid
- Kansè nan tete25 etid
- Kansè Metastatik25 etid
- Kansè Poumon ki pa ti selil21 etid
- Kansè ovè19 etid
- Twoub Spektòm Otis17 etid
- Kansè poumon17 etid
- Ensifizyans kadyak15 etid
- Kansè pwostat15 etid
- Otis13 etid
- Leksemi limfoblastik egi13 etid
- Kansè kolorektal13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.